Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MATINAS BIOPHARMA HOLDINGS, INC.

(MTNB)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about MATINAS BIOPHARMA HOLDINGS, INC.
06:37aMATINAS BIOPHARMA : Provides Business Update and 2022 Strategic Outlook - Form 8-K
PU
06:31aMatinas BioPharma Provides Business Update and 2022 Strategic Outlook
GL
01/18Matinas BioPharma to Provide Corporate Update and 2022 Business Outlook on January 25, ..
AQ
2021Matinas BioPharma Says Data Monitoring Panel Backs Continuation of Meningitis Trial to ..
MT
2021MATINAS BIOPHARMA : Announces Unanimous DSMB Approval to Progress into Fourth and Final Co..
PU
2021Matinas BioPharma Announces Unanimous DSMB Approval to Progress into Fourth and Final C..
GL
2021Matinas Biopharma Announces Unanimous Dsmb Approval to Progress into Fourth and Final C..
CI
2021Matinas BioPharma Holdings Names Chief Business Officer
MT
2021MATINAS BIOPHARMA : Appoints Thomas Hoover, M.B.A. as Chief Business Officer - Form 8-K
PU
2021Matinas BioPharma Appoints Thomas Hoover, M.B.A. as Chief Business Officer
GL
2021Matinas BioPharma Appoints Thomas Hoover, M.B.A. as Chief Business Officer
CI
2021Matinas BioPharma to Participate in 33rd Annual Piper Sandler Virtual Healthcare Confer..
AQ
2021Matinas BioPharma Reports Third Quarter 2021 Financial Results and Operational Highligh..
PU
2021Matinas BioPharma Holdings, Inc. Reports Earnings Results for the Third Quarter and Nin..
CI
2021Matinas BioPharma Reports Third Quarter 2021 Financial Results and Operational Highligh..
AQ
More most relevant news
All news about MATINAS BIOPHARMA HOLDINGS, INC.
06:37aMATINAS BIOPHARMA : Provides Business Update and 2022 Strategic Outlook - Form 8-K
PU
06:32aMATINAS BIOPHARMA HOLDINGS, INC. : Regulation FD Disclosure, Other Events, Financial State..
AQ
06:31aMatinas BioPharma Provides Business Update and 2022 Strategic Outlook
GL
01/18Matinas BioPharma to Provide Corporate Update and 2022 Business Outlook on January 25, ..
AQ
2021Matinas BioPharma Says Data Monitoring Panel Backs Continuation of Meningitis Trial to ..
MT
2021MATINAS BIOPHARMA : Announces Unanimous DSMB Approval to Progress into Fourth and Final Co..
PU
2021MATINAS BIOPHARMA HOLDINGS, INC. : Regulation FD Disclosure, Other Events, Financial State..
AQ
2021Matinas BioPharma Announces Unanimous DSMB Approval to Progress into Fourth and Final C..
GL
2021Matinas Biopharma Announces Unanimous Dsmb Approval to Progress into Fourth and Final C..
CI
2021Matinas BioPharma Holdings Names Chief Business Officer
MT
More news
News in other languages on MATINAS BIOPHARMA HOLDINGS, INC.
2021Matinas BioPharma déclare que le comité de surveillance des données approuve la poursui..
2021Matinas BioPharma Holdings nomme un directeur commercial en chef
2021Matinas BioPharma administre le premier patient d'une étude de phase 1 sur un candidat ..
2021Matinas déclare que le MAT2203 dépasse le seuil du critère d'évaluation primaire de la ..
2021Matinas BioPharma obtient un brevet américain sur le MAT2203 pour le traitement ou la p..
2021Matinas BioPharma reçoit l'approbation conditionnelle de la FDA pour le Lypdiso comme n..
2020Matinas BioPharma collabore avec le NIAID pour tester les formulations orales du Remdes..
2020Matinas BioPharma reçoit une subvention pouvant atteindre 3,75 millions de dollars pour..
More news
Analyst Recommendations on MATINAS BIOPHARMA HOLDINGS, INC.
2021MATINAS BIOPHARMA : Piper Sandler Cuts Matinas BioPharma Holdings to Neutral From Overweig..
MT
2021MATINAS BIOPHARMA : HC Wainwright Adjusts Price Target on Matinas BioPharma Holdings to $3..
MT
More recommendations
Press releases
06:37aMATINAS BIOPHARMA : Provides Business Update and 2022 Strategic Outlook - Form 8-K
PU
06:32aMATINAS BIOPHARMA HOLDINGS, INC. : Regulation FD Disclosure, Other Events, Financial State..
AQ
06:31aMatinas BioPharma Provides Business Update and 2022 Strategic Outlook
GL
01/18Matinas BioPharma to Provide Corporate Update and 2022 Business Outlook on January 25, ..
AQ
2021MATINAS BIOPHARMA : Announces Unanimous DSMB Approval to Progress into Fourth and Final Co..
PU
More press releases
Upcoming event on MATINAS BIOPHARMA HOLDINGS, INC.